The importance of hemoglobin A2 (HbA2) as an indicator of the presence of β-thalassemia was established many years ago. However, clinical application of recommended HbA2 cut off values is often hampered due to poor equivalence of HbA2 results among methods and laboratories. Thus, the IFCC standardization program for HbA2 was initiated in 2004 with the goal of achieving a complete reference system for this measurand. HbA2 standardization efforts are still in progress, including the development of a higher-order HbA2 reference measurement procedure and the preparation of a certified reference material in collaboration with the IRMM. Here, we review the past, present and future of HbA2 standardization and describe the current status of HbA2 testing.

Developing a reference system for the IFCC standardization of HbA2 / R. Paleari, D. Caruso, P. Kaiser, C.G. Arsene, C. Schaeffer Reiss, A. Van Dorsselaer, E. Bissé, M. Ospina, V.R. De Jesús, B. Wild, A. Mosca. - In: CLINICA CHIMICA ACTA. - ISSN 0009-8981. - 467(2017), pp. 21-26. [10.1016/j.cca.2016.05.023]

Developing a reference system for the IFCC standardization of HbA2

R. Paleari
Primo
;
D. Caruso
Secondo
;
A. Mosca
2017

Abstract

The importance of hemoglobin A2 (HbA2) as an indicator of the presence of β-thalassemia was established many years ago. However, clinical application of recommended HbA2 cut off values is often hampered due to poor equivalence of HbA2 results among methods and laboratories. Thus, the IFCC standardization program for HbA2 was initiated in 2004 with the goal of achieving a complete reference system for this measurand. HbA2 standardization efforts are still in progress, including the development of a higher-order HbA2 reference measurement procedure and the preparation of a certified reference material in collaboration with the IRMM. Here, we review the past, present and future of HbA2 standardization and describe the current status of HbA2 testing.
Analytical goals; Beta-thalassemia; Quality control; Reference materials; Reference measurement procedure; Standardization; Biochemistry; Clinical Biochemistry; Biochemistry (medical)
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
Article (author)
File in questo prodotto:
File Dimensione Formato  
2016_HbA2_IFCCWG_CCA.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.42 MB
Formato Adobe PDF
1.42 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S0009898116302352-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 916.62 kB
Formato Adobe PDF
916.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/500944
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 3
social impact